Filing Details

Accession Number:
0000950142-19-001098
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-15 14:49:28
Reporting Period:
2019-05-13
Accepted Time:
2019-05-15 14:49:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1408443 Milestone Pharmaceuticals Inc. MIST () XX
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
903337 Quebec Du Travailleurs Des Solidarite De Fonds 545 Cremazie East #200
Montreal Quebec
Montreal A8 H2M 2W4
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2019-05-13 139,849 $0.00 170,416 No 4 C Direct
Common Shares Acquisiton 2019-05-13 798,974 $0.00 969,390 No 4 C Direct
Common Shares Acquisiton 2019-05-13 574,292 $0.00 1,543,682 No 4 C Direct
Common Shares Acquisiton 2019-05-13 437,203 $0.00 1,980,885 No 4 C Direct
Common Shares Acquisiton 2019-05-13 306,092 $0.00 2,286,977 No 4 C Direct
Common Shares Acquisiton 2019-05-13 433,333 $15.00 2,720,310 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Series A-1 Preferred Disposition 2019-05-13 139,849 $0.00 139,849 $0.00
Common Shares Series A-2 Preferred Disposition 2019-05-13 798,974 $0.00 798,974 $0.00
Common Shares Series B Preferred Disposition 2019-05-13 574,292 $0.00 574,292 $0.00
Common Shares Series C Preferred Disposition 2019-05-13 437,203 $0.00 437,203 $0.00
Common Shares Series D-1 Preferred Disposition 2019-05-13 306,092 $0.00 306,092 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering.